WINNIPEG, MANITOBA--(Marketwire - June 25, 2008) - Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce that the Company has been given a Notice of Allowance from the Canadian Intellectual Property Office for the DispersinB™ trademark application.
